| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 2.6 | 3.3 |
| Gross profit | 1.5 | 1.9 |
| Net income | -0.8 | -0.2 |
| EPS (diluted, $ a share) | $0.00 | $0.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -21.6% |
|---|---|
| Gross margin | 58.9% |
| Operating margin | -30.5% |
10-Q filed with the SEC, OTC: INIS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Radnostix Inc: key numbers
- Share price
- $0.0357Close, Nov 17
- Market cap
- $19.4M
- Shares outstanding
- 542.15MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Industrial Instruments For Measurement, Display, and ControlSIC 3823
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Radnostix Inc
All →Radnostix Divestiture to Nano Nuclear Energy Inc. for $13.5M
Radnostix Inc. entered into a definitive agreement to sell its depleted uranium deconversion and fluorine extraction assets, including an NRC license and related patents, to Nano Nuclear Energy Inc. for $13.5 million. The consideration consists of $9.5 million in cash and $4 million in Nano Nuclear restricted common stock, allowing Radnostix to focus on its core radioisotope technology segments.
- Value
- $13.5M
- Counterparty
- Nano Nuclear Energy Inc.